Your browser doesn't support javascript.
loading
'I make sure my doctor doesn't know that I use meth': perceived barriers to pre-exposure prophylaxis (PrEP) uptake among community peer educators in Seattle (WA, USA).
McMahan, Vanessa M; Violette, Lauren R; Andrasik, Michele P; Martin, Aleks; Garske, Lindsay; Stekler, Joanne D.
Afiliação
  • McMahan VM; Department of Medicine, University of Washington, 325 9th Avenue, Seattle, WA, 98104, USA; and Corresponding author. Email: vmcmahan@uw.edu.
  • Violette LR; Department of Medicine, University of Washington, 325 9th Avenue, Seattle, WA, 98104, USA.
  • Andrasik MP; Department of Global Health, University of Washington, 1510 San Juan Road, Seattle, WA, 98195 USA; and Fred Hutch, HIV Vaccine Trials Network, 1100 Fairview Avenue N, Seattle, WA, 98109, USA.
  • Martin A; Project NEON, Seattle Counseling Service, 1216 Pine Street, Suite 300, Seattle, WA, 98101, USA.
  • Garske L; Project NEON, Seattle Counseling Service, 1216 Pine Street, Suite 300, Seattle, WA, 98101, USA.
  • Stekler JD; Department of Medicine, University of Washington, 325 9th Avenue, Seattle, WA, 98104, USA; and Department of Global Health, University of Washington, 1510 San Juan Road, Seattle, WA, 98195 USA; and Department of Epidemiology, University of Washington, 1959 NE Pacific Street Seattle, WA, 98195 USA.
Sex Health ; 17(1): 29-37, 2020 02.
Article em En | MEDLINE | ID: mdl-31954432
ABSTRACT
Background HIV disproportionately affects cisgender men and transgender people who have sex with men (MSM/TG) and use methamphetamine. Pre-exposure prophylaxis (PrEP) uptake has been slow in this group. It is important to understand perceptions about PrEP and barriers to its use among MSM/TG who use methamphetamine to reduce new HIV infections.

METHODS:

We conducted four focus groups with peer educators of a harm reduction program. We assessed their perspectives of PrEP and barriers across the PrEP continuum among MSM/TG who use methamphetamine.

RESULTS:

Notably, stigma related to the multiple marginalised identities of MSM/TG who use methamphetamine (e.g. MSM/TG-related stigma, methamphetamine-related stigma) was a barrier at each step. We developed a framework that combined the PrEP continuum and a stigma-based treatment cascade to explore these themes and describe the effects of stigma on PrEP engagement. Methamphetamine-related barriers were also identified.

CONCLUSIONS:

The findings of this study emphasise the importance of incorporating stigma reduction into PrEP delivery for MSM/TG who use methamphetamine.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Comunicação / Homossexualidade Masculina / Fármacos Anti-HIV / Usuários de Drogas / Profilaxia Pré-Exposição / Metanfetamina Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Sex Health Assunto da revista: DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Comunicação / Homossexualidade Masculina / Fármacos Anti-HIV / Usuários de Drogas / Profilaxia Pré-Exposição / Metanfetamina Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Sex Health Assunto da revista: DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2020 Tipo de documento: Article